Publication | Closed Access

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

ObesityMetabolic SyndromeNutritionDiabetes ManagementLiraglutide Versus PlaceboInsulin ManagementDiabetesDouble-blind TrialType 2Diabetes MellitusMedicine